Ventas stock holds near $91 as consensus targets climb toward $100
Ventas Inc. (VTR) stock is trading around $91.81 on the NYSE, with analysts setting consensus targets between $98 and $100, suggesting an upside potential of approximately 9.3%. The healthcare REIT has a market capitalization of $30.94 billion and a P/E ratio of 20.51, reflecting its position as a large-cap player in healthcare real estate with stable cash flows. The company focuses on senior living communities and medical office buildings, benefiting from demographic trends and providing consistent dividend income for investors.
38,054 Shares in Ventas, Inc. $VTR Acquired by one8zero8 LLC
one8zero8 LLC has acquired a new stake of 38,054 shares in Ventas, Inc. (NYSE:VTR) during the second quarter, valued at approximately $3.379 million. Several other hedge funds also adjusted their positions in Ventas, increasing institutional ownership to 94.18%. The article also notes recent insider buying by Director Michael J. Embler and provides Ventas's financial performance, analyst ratings, and company overview.
Wealthfront Advisers LLC Makes New $9.57 Million Investment in Ventas, Inc. $VTR
Wealthfront Advisers LLC has made a new $9.57 million investment in Ventas, Inc. (NYSE:VTR) by purchasing 107,765 shares during the second quarter. Other institutional investors also increased their stakes, with BlackRock Inc. making a significant purchase of over $4.95 billion. The real estate investment trust reported strong earnings, beating analyst estimates, and analysts have issued "Buy" and "Overweight" ratings with target price increases.
Ventas stock holds after $1.73 billion quarter
Ventas Inc. reported strong quarterly results with revenue reaching $1.73 billion, a 21.7% year-over-year increase, and EPS at $0.97, slightly above the consensus. The healthcare REIT, with a market capitalization of $46.80 billion, saw its stock trading at $89.11, below its 52-week high but showing significant growth from the previous year. Analysts anticipate full-year earnings of $3.89 per share, indicating that the quarter serves as a crucial checkpoint for future performance.
Oxbow Advisors LLC Acquires Shares of 19,733 Ventas, Inc. $VTR
Oxbow Advisors LLC has acquired 19,733 shares of Ventas, Inc. (NYSE:VTR) in the second quarter, valued at approximately $1.75 million. This investment comes as institutional investors collectively own a significant 94.18% of Ventas stock, and analysts maintain a "Moderate Buy" rating with an average price target of $98. Ventas recently surpassed quarterly expectations, reporting $0.97 earnings per share and $1.73 billion in revenue, marking a 21.7% year-over-year increase.
Mitsubishi UFJ Asset Management Co. Ltd. Acquires New Shares in Ventas, Inc. $VTR
Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new stake in Ventas, Inc. (NYSE:VTR) during the second quarter, purchasing over 1.58 million shares valued at approximately $140.44 million. This move positions Mitsubishi UFJ Asset Management as a significant institutional investor in Ventas, a real estate investment trust specializing in healthcare properties. Other institutional investors have also recently adjusted their holdings in VTR, which has a consensus analyst rating of "Moderate Buy" and an average price target of $98.00.
55,781,968 Shares in Ventas, Inc. $VTR Acquired by BlackRock Inc.
BlackRock Inc. has acquired a new stake of 55,781,968 shares in Ventas, Inc. (NYSE:VTR) during the second quarter, valued at approximately $4.95 billion, making BlackRock Inc. the owner of about 10.87% of Ventas. Other institutional investors also adjusted their holdings in Ventas. The article also provides Ventas' stock performance, financial metrics, recent earnings report, and analyst ratings, with the company currently holding a "Moderate Buy" consensus rating.
Ventas’ Sustainability Push and Dividend Hike: Is VTR Reframing Its Long‑Term Value Story?
Ventas, Inc. recently released its 2025–2026 Corporate Sustainability Report and increased its annual dividend to US$0.52 per quarter, signaling a commitment to long-term value creation. These actions reinforce its existing income and resilience narrative, aligning with stakeholder priorities for an aging population. While the dividend hike makes waiting for NOI growth more palatable, investors should still monitor the impact of rising exposure to the SHOP segment and continue to compare multiple perspectives before investing.
Ventas stock holds firm after $1.73 billion quarter
Ventas Inc. (VTR) stock is holding firm after reporting a strong quarter with $1.73 billion in revenue and $0.97 EPS, both exceeding estimates. The healthcare REIT, with a market cap of $46.77 billion, has a 52-week range of $66.38 to $101.60 and analysts anticipate further earnings growth, with a consensus target price of $98.00. Investors are now watching occupancy and lease income trends in healthcare real estate as the stock trades below the average target.
Pallas Capital Advisors LLC Acquires Shares of 96,841 Ventas, Inc. $VTR
Pallas Capital Advisors LLC recently acquired 96,841 shares of Ventas, Inc. (NYSE:VTR) during the second quarter, valued at approximately $8.599 million. This transaction highlights increasing institutional interest, with other major firms like Deutsche Bank AG and Mitsubishi UFJ Asset Management Co. Ltd. also purchasing significant stakes. Ventas, a healthcare-focused REIT, reported strong quarterly earnings, beating analyst expectations, and maintains a "Moderate Buy" consensus rating from analysts.
Diamond Hill Capital Management LLC Investment Advisor Acquires New Shares in Ventas, Inc. $VTR
Diamond Hill Capital Management LLC Investment Advisor has acquired a new position in Ventas, Inc. (NYSE:VTR), purchasing 98,823 shares valued at approximately $8.775 million. Other institutional investors have also recently adjusted their stakes in the healthcare REIT. Additionally, a Ventas director recently increased their holdings through an insider purchase.
5,088,082 Shares in Ventas, Inc. $VTR Purchased by Deutsche Bank AG
Deutsche Bank AG recently acquired a new stake of 5,088,082 shares in Ventas, Inc. (NYSE:VTR) during the second quarter, valued at approximately $451.82 million. This purchase gives Deutsche Bank AG a 0.99% ownership of the real estate investment trust. Other institutional investors have also adjusted their holdings in Ventas, and a director of the company recently bought 2,500 shares.
Ventas adds sustainability goals as it completes ‘highest-impact’ energy efficiency initiatives
Ventas, a Chicago-based REIT, has announced new corporate sustainability goals, building on already completed high-impact energy efficiency initiatives. The company is adjusting its 2030 energy use intensity reduction target from 25% to 15% and has integrated electrification and renewable goals into its net-zero plan for greater flexibility. Ventas is also making strides in water efficiency and waste reduction across its senior housing operating portfolio.
Ventas Releases 2025-2026 Corporate Sustainability Report
Ventas, Inc. (NYSE: VTR) has released its 2025-2026 Corporate Sustainability Report (CSR), detailing initiatives that support its business strategy and aim to create long-term value for a growing aging population. The report highlights sustainable business practices, a focus on exceptional employees, and high standards of corporate governance. Ventas continues to be recognized for its sustainability leadership and aligns its reporting with GRI Standards, IFRS S2, and UN SDGs.
Ventas (VTR) Could Be a Great Choice
Ventas (VTR) is highlighted as a potentially strong investment for income investors due to its consistent dividend payouts and solid earnings growth. The company, headquartered in Chicago and operating in the Finance sector, currently offers a dividend yield of 2.27% and has an annualized dividend of $2.08, representing an 8.3% increase from last year. With a Zacks Rank of #3 (Hold) and expected earnings growth of 11.78% for 2026, VTR is presented as a compelling option despite rising interest rates.
Ventas Releases 2025-2026 Corporate Sustainability Report
Ventas, Inc. (NYSE: VTR) has released its 2025-2026 Corporate Sustainability Report (CSR), detailing its initiatives to support its business strategy, enhance asset performance, and create long-term value amidst growing demand from the aging population. The report highlights three pillars: Sustainable Business, Exceptional Employees, and High Standards, reflecting the company's commitment to efficiency, talent development, and strong governance. Ventas continues to be recognized for its corporate sustainability leadership, aligning its reporting with Global Reporting Initiative (GRI) Standards and IFRS Sustainability Disclosure Standards.
14,344 Shares in Ventas, Inc. $VTR Bought by Focus Partners Advisor Solutions LLC
Focus Partners Advisor Solutions LLC purchased 14,344 shares of Ventas, Inc. (NYSE:VTR) in the second quarter, valued at approximately $1.27 million. This acquisition highlights continued institutional interest, with 94.18% of the healthcare REIT owned by such investors. Director Michael J. Embler also increased his stake by nearly 15%, reflecting insider confidence, while analysts maintain a "Moderate Buy" rating with a $98 price target for the stock.
Ventas (NYSE:VTR) Stock Forecast & Analyst Predictions
Ventas (NYSE:VTR) is forecast to grow earnings by 29.2% and revenue by 10.5% per annum, with EPS expected to increase by 28.1% annually. Recent updates include increased earnings guidance for 2026, positive Q2 2026 earnings exceeding analyst expectations, and a slight increase in the consensus price target. The company also announced key leadership changes and an acquisition while managing shareholder dilution and insider stock sales.
SCS Capital Management LLC Makes New Investment in Ventas, Inc. $VTR
SCS Capital Management LLC has made a new investment in Ventas, Inc. (NYSE:VTR), acquiring 298,587 shares valued at approximately $26.65 million. This move positions SCS Capital Management with a 0.06% stake in the healthcare REIT, which is largely owned by institutional investors (94.18%). Analysts maintain a "Moderate Buy" consensus rating for Ventas, with an average price target of $98, indicating potential upside from its current trading levels.
110,040 Shares in Ventas, Inc. $VTR Bought by ABN AMRO Bank N.V.
ABN AMRO Bank N.V. recently acquired 110,040 shares of Ventas, Inc. (NYSE:VTR) valued at approximately $9.79 million during the second quarter. Other institutional investors like Deutsche Bank AG, Bank of New York Mellon Corp, and Norges Bank also increased their stakes or bought new positions in the real estate investment trust. Analysts have a "Moderate Buy" consensus rating for Ventas, with a target price of $98.00.
Fidelity SAI Real Estate Index Fund's Ventas Inc(VTR) Holding History
This article details Fidelity SAI Real Estate Index Fund's historical holdings in Ventas Inc (VTR). As of April 30, 2026, the fund held 53,976 shares of VTR valued at $4.74 million, representing 2.56% of its portfolio. Since its initial trade in 2019Q4, the fund has made 13 purchases and 13 sales of VTR shares, resulting in an estimated gain of $3.88 million.
Should Welltower’s (WELL) Dividend and Tech Focus Reframe Its Senior Housing Investment Narrative?
Welltower Inc. recently declared a US$0.85 cash dividend, coinciding with a growing institutional interest, exemplified by Baron Opportunity Fund, in its data-driven operating platform and technology focus for senior housing. This focus aims to improve margins and occupancy, though macro uncertainties and leverage risks remain. While the dividend and tech endorsement are positive, the company's ability to execute on its Welltower Business System will be crucial for investor perception against potential financial pressures.
Transocean Share Surge Narrows Gap to Analyst Consensus View
Transocean (NYSE:RIG) shares gained 0.7% on Friday, closing at $5.76, despite underperforming the broader S&P 500 energy sector. The stock's current price is 11.2% below the analyst consensus target of $6.40, indicating a narrowing gap. The company's proposed acquisition of Valaris Ltd. (NYSE:VAL) and recent oil price increases are key factors influencing its valuation and future prospects.
RBC Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $99
RBC Capital has reaffirmed its Buy rating on Ventas Inc (VTR.US) and increased its target price for the company's stock to $99. This indicates continued confidence in the real estate investment trust specializing in healthcare properties.
Ventas, Inc. (VTR) discloses $91.9M in institutional equity holdings in latest 13F
Ventas, Inc., an institutional investment manager, filed a Form 13F-HR disclosing its equity holdings. The report indicates one reportable holding with an aggregate value of $91,930,210. This filing provides transparency into Ventas's investment portfolio, with no other managers sharing reporting responsibility.
Ventas Inc. stock outperforms competitors on strong trading day
Ventas Inc. (VTR) shares rose 1.36% to $91.52 on Friday, marking its third consecutive day of gains, despite a generally negative trading session for the broader market. The S&P 500 Index fell 0.17% and the Dow Jones Industrial Average dropped 0.20%, indicating Ventas Inc.'s strong performance relative to its competitors.
Ventas (NYSE:VTR) Given New $99.00 Price Target at Royal Bank Of Canada
Royal Bank of Canada has raised its price target for Ventas (NYSE:VTR) to $99.00 from $98.00, maintaining an "outperform" rating, which suggests an 8.58% upside. Other analysts have also issued positive ratings, contributing to a consensus "Moderate Buy" rating with an average target of $98.00. Institutional investors and hedge funds own a significant portion of the company's stock, and a recent insider purchase by Director Michael J. Embler further indicates confidence in the real estate investment trust.
Owens Corning Stock And Other Rate Sensitive Real Estate Names As Yields Ease
This article highlights Owens Corning (OC), Janus Living (JAN), and Gaming and Leisure Properties (GLPI) as rate-sensitive real estate stocks that could benefit from easing inflation and Treasury yields. It provides an overview of each company's operations, market capitalization, and financial considerations, including growth potential, capital returns, debt, and dividend stability. The piece suggests these stocks warrant closer examination by investors tracking macro trends.
How Investors May Respond To Alexandria Real Estate Equities (ARE) US$1 Billion Junior Subordinated Notes Deal
Alexandria Real Estate Equities (ARE) has issued US$1 billion in junior subordinated notes to enhance balance sheet flexibility and fund corporate purposes. While this debt could alleviate short-term pressure, it doesn't resolve key challenges like leasing traction, weaker demand, and declining net operating income (NOI) highlighted in recent earnings. Investors need to consider how this additional debt will interact with existing pressures, especially given the context of higher vacancies and slower tenant decisions.
Understanding the Setup: (VTR) and Scalable Risk
Ventas Inc. (NYSE: VTR) is showing weak near and mid-term sentiment, which could challenge its long-term positive outlook. Stock Traders Daily's AI models have identified an exceptional 23.4:1 risk-reward short setup targeting a 6.8% downside against a 0.3% risk. The analysis includes various trading strategies and multi-timeframe signal insights for institutional investors.
Ventas Inc. stock underperforms Thursday when compared to competitors despite daily gains
Ventas Inc. (VTR) stock gained 1.44% on Thursday, closing at $90.29, despite the S&P 500 Index and Dow Jones Industrial Average also seeing gains. This marks the second consecutive day of increases for Ventas, although the article title suggests it underperformed compared to its competitors.
BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $107
BMO Capital has reiterated its Buy rating on Ventas Inc. (VTR.US) and increased its price target for the company's stock to $107. This updated target suggests BMO Capital sees significant upside potential for Ventas Inc. shares.
BOK Financial Director Steven Bangert Sells 1,250 Shares at $143.96 Each
BOK Financial Director Steven Bangert sold 1,250 shares of the company's common stock at $143.96 per share on August 11, 2026. This transaction was disclosed in a Form 4 filed with the SEC on August 12, 2026. Following the sale, Bangert directly holds 31,710 shares and indirectly holds 10,436 shares through Bangert Family Investments, LLLP.
Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating
Jefferies has adjusted its price target for Ventas (VTR) down to $102 from $109, while reiterating a Buy rating on the stock. This adjustment comes amidst other recent analyst revisions for Ventas, including BMO Capital raising its target to $107 and Citigroup raising its target to $110, both maintaining positive ratings. Ventas specializes in owning and managing healthcare and medical-residential facilities across the US, Canada, and the UK.
Ventas Inc. stock underperforms Tuesday when compared to competitors
Ventas Inc. (VTR) shares fell by 5.43% to $86.96 on Tuesday, underperforming the broader market as both the S&P 500 Index and Dow Jones Industrial Average also declined. This marked the second consecutive day of losses for Ventas Inc.
Are Wall Street Analysts Bullish on Ventas Stock?
Ventas, Inc. (VTR), a healthcare-focused REIT, has significantly outperformed the broader market and its real estate peers over the past year. Despite a slight dip after its Q2 2026 earnings release due to concerns about equity dilution from aggressive acquisition plans, the company reported strong financial growth, including a 9% year-over-year FFO increase. Analysts maintain a "Strong Buy" consensus rating with an average price target suggesting an 8% upside.
American Healthcare REIT Drops 5.2% Amid Sector-Wide Selling
American Healthcare REIT (AHR) experienced a 5.2% decline on Tuesday, closing at $52.59, as a broader sell-off impacted the entire healthcare real estate sector. This synchronized drop, also affecting peers like Ventas (VTR), CareTrust REIT (CTRE), and Jamestown (JAN), suggests a shift in investor sentiment possibly due to interest rate expectations or economic concerns rather than company-specific issues. The significant trading volume indicates institutional repositioning, raising questions about ongoing sector-wide headwinds.
Ventas Slides 3.8% as Investors Appear to Take Profits After Strong Run
Ventas (VTR) shares fell 3.8% due to profit-taking after a strong rally and REIT sensitivity to interest rates, despite reporting strong Q2 2026 results and raising full-year guidance. The company also aggressively pursued external growth with significant senior housing investments. The article details insider trading, hedge fund activity, congressional stock trading, and analyst price targets for VTR.
BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating
BMO Capital has increased its price target for Ventas (VTR) to $107 from $105, while maintaining an "Outperform" rating on the stock. This adjustment reflects a positive outlook from the analyst firm on the healthcare and medical-residential facilities REIT. The article also lists recent price target adjustments from other firms, indicating active analyst coverage for Ventas.
NESR Stock Jumped 23% After Reporting Q2 Earnings Monday. Here’s What the Print Says.
National Energy Services Reunited (NESR) stock surged 23% after reporting a record Q2 2026, with revenue of $521 million and adjusted EPS of $0.44, both significantly beating estimates, driven largely by the Jafurah gas project. Despite the surge pushing NESR stock above analyst targets, TIKR's model still projects substantial upside, valuing the stock at $86 due to continued growth expectations from Jafurah, new technology agreements, and the 3B3 plan. The article highlights that analysts have consistently played catch-up with NESR's stock performance, with current targets trailing the market price.
How Investors May Respond To Sabra Health Care REIT (SBRA) Profit Reversal And Steady Dividend
Sabra Health Care REIT (SBRA) recently reported a swing to a net loss of US$25.2 million in Q2 2026 despite increased revenue, while maintaining its quarterly dividend of US$0.30 per share. This situation raises questions about dividend coverage and financial flexibility, especially given the company's reliance on high dividend payouts amidst weaker profitability. Investors are encouraged to consider the implications of this mixed financial performance on the company's long-term investment narrative, particularly regarding its ability to sustain cash flows from senior housing and skilled nursing demand.
Ventas Inc. stock underperforms Monday when compared to competitors
Ventas Inc. (VTR) shares fell 1.51% on Monday, closing at $91.95, while the broader market indices, S&P 500 and Dow Jones Industrial Average, experienced minor declines. The stock is currently 9.50% below its 52-week high of $101.60 reached on July 28th.
American Healthcare REIT (NYSE: AHR) lines up $873M Kensington senior housing acquisition
American Healthcare REIT (AHR) plans to acquire the Kensington Portfolio, comprising eight senior housing communities with 745 units across four states, for $873 million. The transaction is structured with multiple purchase agreements and financing through equity offerings, credit agreement borrowings, debt assumption, and cash. Key conditions include lender consent and stabilization of net operating income for certain properties, with initial closing targeted for September 1, 2026.
Raised 2026 Earnings Outlook On Senior Housing Strength Might Change The Case For Investing In Ventas (VTR)
Ventas, Inc. (VTR) recently reported Q2 2026 results, slightly raising its full-year 2026 net income per share guidance to US$0.58-$0.63 due to strong senior housing operating performance and increased investment in that segment. This updated outlook, coupled with a US$4.5 billion investment pipeline, reinforces the company's focus on senior housing, but also highlights risks if occupancy or operator execution falters. While Simply Wall St's fair value estimate is US$99.05, community estimates vary widely, underscoring the importance of analyzing how effectively Ventas can convert
Raised 2026 Earnings Outlook On Senior Housing Strength Might Change The Case For Investing In Ventas (VTR)
Ventas (VTR) recently reported Q2 2026 results, showing revenue of US$1.73 billion and net income of US$70.57 million. The company modestly raised its full-year 2026 attributable net income per share guidance, attributing this increased confidence to strong senior housing operating performance and planned investments in that segment. This updated outlook and increased senior housing exposure highlight the importance of execution in acquisitions and operations for near-term earnings growth, though it also introduces risks if occupancy or operator performance falters.
Alexandria Real Estate Equities (ARE) Reports Weaker Second Quarter Results, Does It Look Fairly Valued?
Alexandria Real Estate Equities (ARE) reported weaker Q2 2026 results with lower sales and revenue but a narrower net loss. Despite a recent share price rebound, the long-term outlook is pressured due to reassessed risk and growth potential. Analysts view the stock as 2.5% undervalued with a consensus price target of $51, though risks from biotech funding and leasing persist.
American Healthcare REIT, CareTrust, National HealthCare Corp., Strawberry Fields deliver second-quarter earnings reports
American Healthcare REIT, CareTrust REIT, National HealthCare Corp., and Strawberry Fields reported their second-quarter earnings. American Healthcare REIT saw double-digit same-store net operating growth, while CareTrust REIT recorded its largest single investment quarter in history, driven by skilled nursing expansion. National HealthCare Corp.'s net operating revenues increased by 8.8% year-over-year, largely due to skilled nursing facility acquisitions, and Strawberry Fields REIT collected 100% of contractual rents and secured a new credit facility for acquisition growth.
Medical Properties Trust (NYSE:MPT): 7.7% Yield Puts Spotlight on Cash-Flow Resilience
Medical Properties Trust (MPT) finished the week with a 1.5% rise, trading at $4.70, and is set to announce Q2 earnings. The company offers a 7.7% annual yield, with consensus FFO estimates suggesting the dividend is well-covered, though operating cash flow remains a challenge due to increased interest expenses. Investors will closely watch cash rent, operating cash flow, debt repayments, and dividend comments, as MPT explores various liquidity options amidst elevated risks.
Medical Properties Trust (MPW) Is Negotiating To Reopen Norwood Hospital
Medical Properties Trust (MPW) is currently in negotiations to reopen Norwood Hospital, which has been closed since 2020. Massachusetts lawmakers have set a November 1 deadline for a redevelopment agreement, with the threat of eminent domain if talks fail. This situation highlights MPW's strategy of re-tenanting challenged hospitals and its ability to manage distressed assets, while also bringing regulatory and interest rate risks into focus for investors.
San Jose Area Senior Multifamily Community Sells for $103M
American Healthcare REIT has acquired Avella at Almaden, a 200-unit luxury senior community in San Jose, Calif., for $102.8 million. The property, originally developed by The 11th Group Inc., Affinius Capital, and Alliance Residential, offers assisted living and memory care units with various amenities. It was brought online in 2020 and had a $59.2 million refinancing loan originated in 2023 by Walton Street Capital.
